INSMED Inc

Pharmaceutical Preparations·BRIDGEWATER, NJ·FY end 12/31·CIK 1104506

CEO Pay Ratio

—

William H. Lewis

CEO Total Comp

$10.4M

William H. Lewis

Median Employee

$269,559

Revenue

$606.4M

FY 2025

Net Income

-$1.3B

FY 2025

Free Cash Flow

-$967.6M

FY 2025

Net Margin

-210.5%

Insider Net (180d)

-$42.6M

0 buys / 65 sales

CEO Pay Accountability

CEO comp as % of net income

-1.39%

For every $1,000 of profit, $-13.89 flows to the CEO.

CEO comp as % of buybacks

—

No buyback data for the most recent fiscal year.

5-year history · USD

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	Trend
Revenue	$606.4M	$363.7M	$305.2M	$245.4M	$188.5M
Gross Profit	—	—	—	—	—	—
Operating Income	-$1.2B	-$878.3M	-$709.6M	-$457.3M	-$375.1M
Net Income	-$1.3B	-$913.8M	-$749.6M	-$481.5M	-$434.7M
Operating CF	-$935.0M	-$683.9M	-$536.2M	-$400.4M	-$363.3M
Capex	$32.6M	$21.9M	$13.3M	$9.9M	$7.3M
Free Cash Flow	-$967.6M	-$705.8M	-$549.5M	-$410.3M	-$370.6M
Buybacks	—	—	—	—	—	—
Dividends	—	—	—	—	—	—

Gross Margin	—	—	—	—	—	—
Operating Margin	-205.6%	-241.5%	-232.5%	-186.4%	-199.0%
Net Margin	-210.5%	-251.2%	-245.6%	-196.3%	-230.6%
FCF Margin	-159.6%	-194.1%	-180.1%	-167.2%	-196.6%
R&D / Revenue	127.2%	164.5%	187.1%	162.0%	144.7%
Effective Tax	-0.4%	-0.4%	-0.3%	-0.3%	0.4%
Debt / Equity	1.47	7.80	-7.03	25.92	3.33
Buybacks / FCF	—	—	—	—	—	—

FY 2023

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
William H. LewisCEO	$780.0K	$2.2M	$6.6M	$702.0K	$106.4K	$10.4M
Sara BonsteinChief Financial Officer	$511.0K	$1.3M	$2.4M	$276.0K	$23.4K	$4.6M
Martina FlammerM.D. Chief Medical Officer	$555.7K	$1.1M	$2.2M	$300.1K	$16.5K	$4.2M
Roger AdsettChief Operating Officer	$577.0K	$750.0K	$2.2M	$346.2K	$85.3K	$4.0M
Drayton WiseChief Commercial Officer	$530.0K	$750.0K	$2.2M	$292.2K	$66.6K	$3.9M